Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons.
Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons.
复制标题
SLC34A2 变异与人类和狒狒中钠-锂反转运活动的关联。
DOI:
10.1038/ajh.2008.355
复制
发表时间:
2009
影响因子:
3.2
通讯作者:
Ferrell,RobertE
中科院分区:
文献类型:
--
作者:
Zheng,Xiaojing;Kammerer,CandaceM;Cox,LauraA;Morrison,Alanna;Turner,StephenT;Ferrell,RobertE
BackgroundSodium–lithium countertransport (SLC) activity, an intermediate phenotype of essential hypertension, has been linked to a region of baboon chromosome 5, homologous to human chromosome 4p. HumanSLC34A2, located at chromosome 4p15.1–p15.3, is a positional candidate gene for SLC. The specific aim of this study was to identify genetic variants of theSLC34A2gene in both baboon and human, and to examine the relationship of these polymorphisms with SLC activity and blood pressure.MethodsSingle-nucleotide polymorphism (SNP) was identified by sequencing theSLC34A2gene in 24 baboon founders and 94 unrelated individuals. All tag SNPs inSLC34A2were genotyped in 1,856 individuals from 252 pedigrees of mixed European ancestry. Three SNPs in baboon were genotyped in 634 baboons comprising 11 pedigrees.ResultsIn human, one SNP (rs12501856) was found to be significantly associated with SLC individually, though it did not pass multiple testing correction; however, haplotype 2 containing allele C of SNP rs12501856 showed strong evidence of association with SLC (P= 0.0037) after multiple comparison adjustment. This haplotype was also marginally associated with diastolic blood pressure and systolic blood pressure. This finding was confirmed in baboons, where a highly significant association was detected between SLC and baboon SNPAsn136Asn(P= 0.0001). However, the associated SNP did not account for the linkage signal on baboon chromosome 5.ConclusionsConsistent results in two different species imply thatSLC34A2is associated with SLC activity and blood pressure.American Journal of Hypertension2009; doi:10.1038/ajh.2008.355
登录
查看更多内容
影响因子:
9.8
作者:
Almasy, L;Blangero, J
通讯作者:
Blangero, J
影响因子:
2.7
作者:
A. Obasohan;C. Osuji;I. Oforofuo
通讯作者:
I. Oforofuo
DOI:
10.1161/01.hyp.13.4.378
发表时间:
1989
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Turner,ST;Weidman,WH;Michels,VV;Reed,TJ;Ormson,CL;Fuller,T;Sing,CF
通讯作者:
Sing,CF
DOI:
10.1161/01.hyp.20.6.841
发表时间:
1992
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Turner,ST;Rebbeck,TR;Sing,CF
通讯作者:
Sing,CF
DOI:
10.1016/0009-8981(96)06389-9
发表时间:
1996
期刊:
Clinica chimica acta; international journal of clinical chemistry
影响因子:
--
作者:
K. Tournoy;J. Delanghe;D. Duprez;M. D. De Buyzere;R. Verbeeck;D. Vergauwe;G. Leroux;D. Clement
通讯作者:
D. Clement